Vitamin K-dependent protein C(PROC)

Reference:
Product nameVitamin K-dependent protein C(PROC)
Uniprot IDP04070
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMWQLTSLLLFVATWGISGTPAPLDSVFSSSERAHQVLRIRKRANSFLEELRHSSLERECIEEICDFEEAKEIFQNVDDTLAFWSKHVDGDQCLVLPLEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCTHYCLEEVGWRRCSCAPGYKLGDDLLQCHPAVKFPCGRPWKRMEKKRSHLKRDTEDQEDQVDPRLIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRDKEAPQKSWAPGSHHHHHH
Protein delivered with Tag?C-terminal His Tag
Purity estimated>90%by SDS-PAGE
BufferPBS, pH7.5
Delivery conditionDry Ice
Delivery lead time in business daysEurope: 5-7 working days
USA & Canada: 7-10 working days
Rest of the world: 5-12 working days
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesMammalian cells
Fragment TypeMet1-Pro461
Aliases /SynonymsAnticoagulant protein C,Autoprothrombin IIA,Blood coagulation factor XIV
ReferencePX-P4631
NoteFor research use only

Description of Vitamin K-dependent protein C(PROC)

The Role of Error in Drug Target Proteins

Error is an essential component of any biological system, including the proteins that serve as drug targets. In fact, error is not only inevitable but also necessary for the proper functioning of these proteins. Understanding the structure, activity, and application of error in drug target proteins is crucial for developing effective drugs and treatments. In this article, we will explore the different aspects of error in drug target proteins and its implications in drug discovery and development.

The Structure of Drug Target Proteins

Drug target proteins are specific molecules within the body that are targeted by drugs to produce a therapeutic effect. These proteins are typically enzymes, receptors, or transporters that play a critical role in various biological processes. The structure of drug target proteins is highly complex, with specific amino acid sequences and three-dimensional shapes that determine their function. However, due to the inherent nature of protein synthesis, errors can occur during the formation of these structures.

Types of Errors in Protein Structure

There are two main types of errors that can occur in protein structure: genetic and environmental. Genetic errors, also known as mutations, are changes in the DNA sequence that can lead to changes in the amino acid sequence of a protein. These changes can alter the structure and function of the protein, making it a potential drug target. Environmental errors, on the other hand, are caused by external factors such as temperature, pH, or exposure to toxins, which can also affect the structure of drug target proteins.

The Activity of Drug Target Proteins

The activity of drug target proteins is closely linked to their structure. Any changes in the structure of a protein can affect its activity, making it a potential target for drug development. For example, mutations in the structure of an enzyme can lead to changes in its catalytic activity, while mutations in the structure of a receptor can alter its binding affinity for a drug. These changes in activity can have significant implications for drug discovery and development.

The Role of Error in Protein Activity

Error plays a crucial role in protein activity, as it can lead to the formation of new protein variants with altered activity. These variants can have different functions and may even be more effective drug targets than the original protein. For example, a mutation in the structure of a receptor protein may result in a variant with increased binding affinity for a particular drug, making it a more effective target for treatment.

The Application of Error in Drug Target Proteins

The application of error in drug target proteins is a relatively new concept in drug discovery and development. Traditionally, drug development has focused on identifying specific targets and designing drugs to interact with them. However, with the growing understanding of the role of error in protein structure and activity, there is a shift towards using error to identify new drug targets and develop more effective drugs.

Using Error to Identify New Drug Targets

As mentioned earlier, mutations in the structure of drug target proteins can lead to the formation of new variants with altered activity. These variants can be potential targets for drug development, as they may have different functions or increased drug binding affinity. By studying the effects of error on protein structure and activity, researchers can identify these new variants and explore their potential as drug targets.

Utilizing Error in Drug Design

In addition to identifying new drug targets, error can also be utilized in drug design. By understanding the role of error in protein structure and activity, researchers can design drugs that specifically target these variants. This approach, known as structure-based drug design, has shown promising results in the development of more effective and targeted drugs.

Conclusion

In conclusion, error is an essential aspect of drug target proteins that has significant implications in drug discovery and development. It is not only necessary for the proper functioning of these proteins but also plays a crucial role in identifying new drug targets and designing more effective drugs.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vitamin K-dependent protein C(PROC)”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products